Millennium Management »

Aeglea Biotherapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.3M 109k 21.52
2023-09-30 $463k 38k 12.25

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Amazon Put Option (AMZN)
Meta Platforms Cl A (META)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
salesforce Put Option (CRM)

View all positions for Millennium Management

Top funds holding Aeglea Biotherapeutics

Perceptive Advisors
VR Adviser
Commodore Capital
venBio Select Advisor
Cormorant Asset Management
EcoR1 Capital
Franklin Resources
BVF
Wellington Management Company
Citadel Advisors
Braidwell
Global Endowment Management
First Turn Management
Fairmount Funds Management
Boxer Capital

View all funds holding Aeglea Biotherapeutics